Serum Glial Fibrillary Acidic Protein in Acute Stroke

Affiliations

Editorial

David B Seder. Neurocrit Care. 2020 Aug.

. 2020 Aug;33(1):35-36.

doi: 10.1007/s12028-020-00942-2.

¹ Department of Critical Care Services, Maine Medical Center, Tufts University School of Medicine, 22 Bramhall St, Portland, ME, 04102, USA. sederd@mmc.org.

No abstract available

Comment on

Diagnostic Accuracy of Glial Fibrillary Acidic Protein and Ubiquitin Carboxy-Terminal Hydrolase-L1 Serum Concentrations for Differentiating Acute Intracerebral Hemorrhage from Ischemic Stroke.
Luger S, Jæger HS, Dixon J, Bohmann FO, Schaefer J, Richieri SP, Larsen K, Hov MR, Bache KG, Foerch C; BE FAST III Study Group. Luger S, et al. Neurocrit Care. 2020 Aug;33(1):39-48. doi: 10.1007/s12028-020-00931-5. Neurocrit Care. 2020. PMID: 32096121

1. Brunkhorst R, Pfeilschifter W, Foerch C. Astroglial proteins as diagnostic markers of acute intracerebral hemorrhage-pathophysiological background and clinical findings. Transl Stroke Res. 2010;1(4):246–51. - DOI
1. Foerch C, Niessner M, Back T, et al. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clin Chem. 2012;58(1):237–45. - DOI
1. Dvorak F, Haberer I, Sitzer M, Foerch C. Characterisation of the diagnostic window of serum glial fibrillary acidic protein for the differentiation of intracerebral haemorrhage and ischaemic stroke. Cerebrovasc Dis. 2009;27(1):37–41. - DOI
1. Jung CS, Foerch C, Schänzer A, et al. Serum GFAP is a diagnostic marker for glioblastoma multiforme. Brain. 2007;130(Pt 12):3336–41. - DOI
1. Mayer CA, Brunkhorst R, Niessner M, Pfeilschifter W, Steinmetz H, Foerch C. Blood levels of glial fibrillary acidic protein (GFAP) in patients with neurological diseases. PLoS ONE. 2013;8(4):e62101. - DOI